August 20, 2014 6:48 AM ET

Biotechnology

Company Overview of Aileron Therapeutics, Inc.

Company Overview

Aileron Therapeutics, Inc., a biopharmaceutical company, develops stapled peptide drugs. The company focuses on candidates targeting cancer, infectious, metabolic, and immune/inflammatory diseases. Its stapled peptides penetrate cells throughout the body; and modulate intracellular and extracellular protein-protein interactions, and critical control points for human diseases. The company has a strategic partnership with Roche. Aileron Therapeutics, Inc. was formerly known as Renegade Therapeutics, Inc. The company was incorporated in 2001 and is based in Cambridge, Massachusetts.

281 Albany Street

Cambridge, MA 02139

United States

Founded in 2001

Phone:

617-995-0900

Fax:

617-995-2410

Key Executives for Aileron Therapeutics, Inc.

Co-Founder and Vice President of Corporate Development
Chief Financial Officer and Chief Operating Officer
Age: 45
Chief Scientific Officer and Senior Vice President of Discovery & Innovative Technologies
Age: 59
Chief Medical Officer
Age: 62
Compensation as of Fiscal Year 2014.

Aileron Therapeutics, Inc. Key Developments

Aileron Therapeutics, Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 04:00 PM

Aileron Therapeutics, Inc. Presents at Cowen & Co. 34th Annual Health Care Conference, Mar-04-2014 04:00 PM. Venue: Marriott Copley Place Hotel, Boston, Massachusetts, United States.

Aileron Therapeutics, Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 11:30 AM

Aileron Therapeutics, Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-12-2014 11:30 AM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Joseph A. Yanchik, Founder, Chief Executive Officer, President and Director.

Aileron Therapeutics, Inc. Presents at Boston Biotech Conferences LLC's The New York CEO Conference, Nov-12-2013 11:10 AM

Aileron Therapeutics, Inc. Presents at Boston Biotech Conferences LLC's The New York CEO Conference, Nov-12-2013 11:10 AM. Venue: Apella, 450 East 29th Street, New York, NY 10016, United States. Speakers: Joseph A. Yanchik, Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
The Binding Site Inc United States
Meridian Life Science, Inc. United States
Mojave Therapeutics, Inc. United States
Revimmune, Inc United States
Chantal Pharmaceutical United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 5, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aileron Therapeutics, Inc., please visit www.aileronrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.